WO2008073148A3 - Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders - Google Patents
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders Download PDFInfo
- Publication number
- WO2008073148A3 WO2008073148A3 PCT/US2007/015829 US2007015829W WO2008073148A3 WO 2008073148 A3 WO2008073148 A3 WO 2008073148A3 US 2007015829 W US2007015829 W US 2007015829W WO 2008073148 A3 WO2008073148 A3 WO 2008073148A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microorganisms
- cells
- methods
- compositions
- diseases
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N2333/245—Escherichia (G)
Abstract
Described herein are methods for detecting a microorganism or cell in a subject and methods for detecting, imaging or diagnosing a site, disease, disorder or condition in a subject using microorganisms or cells. Also described are methods which use microorganisms or cells for treating a disease, disorder or condition. Such sites, diseases and disorders include sites of cell proliferation, proliferative conditions, neoplasms, tumors, neoplastic disease, wounds and inflammation. Further described are microorganisms and cells for use in the methods and compositions, combinations and kits, including diagnostic and pharmaceutical compositions, containing a microorganism or cell. Microorganisms and cells described herein include those that bind, sequester or accumulate metal, such as those that provide for metal acquisition, transport, storage and/or metabolism. Additional imaging and therapy agents are also described.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/827,518 US7763420B2 (en) | 2006-07-11 | 2007-07-11 | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
EP07870721.3A EP2044436B1 (en) | 2006-07-11 | 2007-07-11 | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83042206P | 2006-07-11 | 2006-07-11 | |
US60/830,422 | 2006-07-11 | ||
US85238906P | 2006-10-16 | 2006-10-16 | |
US60/852,389 | 2006-10-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008073148A2 WO2008073148A2 (en) | 2008-06-19 |
WO2008073148A3 true WO2008073148A3 (en) | 2009-02-26 |
Family
ID=39512234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/015829 WO2008073148A2 (en) | 2006-07-11 | 2007-07-11 | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
Country Status (4)
Country | Link |
---|---|
US (2) | US7763420B2 (en) |
EP (1) | EP2044436B1 (en) |
TW (1) | TW200819540A (en) |
WO (1) | WO2008073148A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102242081B (en) * | 2010-03-17 | 2013-01-02 | 中国人民解放军南京军区南京总医院 | Super paramagnetic iron oxide particle marked cell for magnetic-resonance tracing in vivo |
US8859256B2 (en) | 2011-10-05 | 2014-10-14 | Genelux Corporation | Method for detecting replication or colonization of a biological therapeutic |
US9005602B2 (en) | 2006-10-16 | 2015-04-14 | Genelux Corporation | Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
Families Citing this family (167)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0109515D0 (en) * | 2001-04-17 | 2001-06-06 | Neg Micon As | A method for transporting a set of large longitudinal items, a package system to be used by the method and use of such a package system |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
US6850788B2 (en) | 2002-03-25 | 2005-02-01 | Masimo Corporation | Physiological measurement communications adapter |
EP1369491A1 (en) * | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
AU2004289953B2 (en) | 2003-06-18 | 2008-09-25 | Genelux Corporation | Modified recombinant vaccina viruses and other microorganisms, uses thereof |
WO2005030122A2 (en) * | 2003-08-13 | 2005-04-07 | Chiron Corporation | Inactivated host cell delivery of polynucleotides encoding immunogens |
TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
US9161696B2 (en) | 2006-09-22 | 2015-10-20 | Masimo Corporation | Modular patient monitor |
US8840549B2 (en) | 2006-09-22 | 2014-09-23 | Masimo Corporation | Modular patient monitor |
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
US20080241865A1 (en) * | 2007-03-26 | 2008-10-02 | National Institute Of Advanced Industrial Science And Technology | Visible to near-infrared light probe comprising complex of cypridina luciferase and quantum dot |
WO2008150496A2 (en) * | 2007-05-31 | 2008-12-11 | Genelux Corporation | Assay for sensitivity to chemotherapeutic agents |
CA2690627C (en) * | 2007-06-15 | 2014-12-02 | Genelux Corporation | Microorganisms for imaging and/or treatment of tumors |
US20090162288A1 (en) * | 2007-07-18 | 2009-06-25 | Nanhai Chen | Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods |
EP2242516A1 (en) * | 2008-01-11 | 2010-10-27 | Genelux Corporation | Methods and compositions for detection of bacteria and treatment of diseases and disorders |
US20120052003A9 (en) * | 2008-05-16 | 2012-03-01 | Szalay Aladar A | Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
BRPI0923572B1 (en) * | 2008-12-23 | 2019-07-30 | REG Life Sciences, LLC | Modified thioesterase enzyme that converts a c10, c12 or c14 acyl-acp substrate into a fatty acid derivative, modified thioesterase-encoding polynucleotide, expression vector, microorganism host cell, and method of manufacturing c10, c12 fatty acid derivative composition or c14 |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
WO2010123845A2 (en) * | 2009-04-21 | 2010-10-28 | University Of Florida Research Foundation, Inc. | Siderophore conjugate immunogenic compositions and vaccines |
US9155471B2 (en) | 2009-05-27 | 2015-10-13 | Lumicell, Inc'. | Methods and systems for spatially identifying abnormal cells |
EP2435096A1 (en) * | 2009-05-27 | 2012-04-04 | Lumicell Diagnostics, Inc. | Methods and systems for spatially identifying abnormal cells |
EP2910630B1 (en) * | 2009-09-25 | 2018-10-24 | REG Life Sciences, LLC | Production of fatty acid derivatives |
US9153112B1 (en) | 2009-12-21 | 2015-10-06 | Masimo Corporation | Modular patient monitor |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US20110229512A1 (en) * | 2010-03-19 | 2011-09-22 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating urinary tract infections |
US9314304B2 (en) | 2010-12-08 | 2016-04-19 | Lumicell, Inc. | Methods and system for image guided cell ablation with microscopic resolution |
US10702614B2 (en) | 2011-02-15 | 2020-07-07 | Albert Einstein College Of Medicine | Radiobacteria for therapy of cancer |
WO2012135743A2 (en) | 2011-03-30 | 2012-10-04 | Gr Intellectual Reserve, Llc | Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same |
WO2012142529A2 (en) | 2011-04-15 | 2012-10-18 | Genelux Corporation | Clonal strains of attenuated vaccinia viruses and methods of use thereof |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
US9943269B2 (en) | 2011-10-13 | 2018-04-17 | Masimo Corporation | System for displaying medical monitoring data |
EP3584799B1 (en) | 2011-10-13 | 2022-11-09 | Masimo Corporation | Medical monitoring hub |
US10307111B2 (en) | 2012-02-09 | 2019-06-04 | Masimo Corporation | Patient position detection system |
US10149616B2 (en) | 2012-02-09 | 2018-12-11 | Masimo Corporation | Wireless patient monitoring device |
KR101372175B1 (en) | 2012-02-14 | 2014-03-12 | 중앙대학교 산학협력단 | Primer and probe for detection of Halomonas sp. and method for detection of Halomonas sp. using the same |
US20140087362A1 (en) | 2012-03-16 | 2014-03-27 | Aladar A. Szalay | Methods for assessing effectiveness and monitoring oncolytic virus treatment |
WO2013139861A1 (en) | 2012-03-20 | 2013-09-26 | Luc Montagnier | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
WO2013146319A1 (en) * | 2012-03-30 | 2013-10-03 | 味の素株式会社 | Diabetes-inducible bacterium |
EP3693010A1 (en) * | 2012-04-06 | 2020-08-12 | Cornell University | Subunit vaccine delivery platform for robust humoral and cellular immune responses |
US20130280170A1 (en) | 2012-04-20 | 2013-10-24 | Aladar A. Szalay | Imaging methods for oncolytic virus therapy |
RU2483114C1 (en) * | 2012-04-27 | 2013-05-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ульяновский государственный университет" | METHOD TO DETECT GENES THAT DETERMINE ADHESINS, HEMOLYSINS, MANNOSE-RESISTANT HAEMAGGLUTININS IN GENITAL STRAINS OF Escherichia coli |
EP2676536A1 (en) | 2012-06-22 | 2013-12-25 | AIT Austrian Institute of Technology GmbH | Method for producing plant seed containing endophytic micro-organisms |
WO2014043606A1 (en) * | 2012-09-14 | 2014-03-20 | The Johns Hopkins University | Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections |
US9749232B2 (en) | 2012-09-20 | 2017-08-29 | Masimo Corporation | Intelligent medical network edge router |
US20140140959A1 (en) | 2012-10-05 | 2014-05-22 | Aladar A. Szalay | Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes |
EP2919796B1 (en) * | 2012-11-19 | 2021-04-28 | Université catholique de Louvain | Use of akkermansia for treating metabolic disorders |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
KR102116734B1 (en) * | 2012-12-21 | 2020-05-29 | 핑후아 리오우 | Ergothioneine production through metabolic engineering |
EP2951283A4 (en) | 2013-02-04 | 2017-01-25 | Seres Therapeutics, Inc. | Compositions and methods |
RU2664479C2 (en) | 2013-02-04 | 2018-08-17 | Серес Терапеутикс, Инк. | Compositions and methods |
EP2954043B1 (en) | 2013-02-05 | 2021-07-28 | University of Saskatchewan | Endophytic microbial symbionts in plant prenatal care |
US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
US9889092B2 (en) | 2013-03-13 | 2018-02-13 | The Board Of Regents Of The University Of Texas System | Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer |
US10813554B2 (en) | 2013-03-14 | 2020-10-27 | Lumicell, Inc. | Medical imaging device and methods of use |
EP2967077A4 (en) | 2013-03-15 | 2016-09-14 | Seres Therapeutics Inc | Network-based microbial compositions and methods |
CN105451750B (en) | 2013-03-29 | 2023-03-10 | 生物医学谷探索股份有限公司 | Clostridium noeukii for the treatment of solid tumors in humans |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US10136646B2 (en) | 2013-06-26 | 2018-11-27 | Indigo Ag, Inc. | Agricultural endophyte-plant compositions, and methods of use |
AU2014302296B2 (en) | 2013-06-26 | 2016-02-25 | Indigo Ag, Inc. | Seed-origin endophyte populations, compositions, and methods of use |
ES2902386T1 (en) | 2013-07-01 | 2022-03-28 | Massachusetts Inst Technology | Functionalization of endogenous bacteria |
CA3209979A1 (en) | 2013-09-04 | 2015-03-12 | Indigo Ag, Inc. | Agricultural endophyte-plant compositions, and methods of use |
US10832818B2 (en) | 2013-10-11 | 2020-11-10 | Masimo Corporation | Alarm notification system |
US9919002B2 (en) | 2013-10-21 | 2018-03-20 | North Carolina State University | Methods and constructs for compound delivery |
AU2014346664B2 (en) | 2013-11-06 | 2017-08-31 | The Texas A & M University System | Fungal endophytes for improved crop yields and protection from pests |
KR102515850B1 (en) | 2013-11-25 | 2023-03-30 | 세레스 테라퓨틱스, 인코포레이티드 | Synergistic bacterial compositions and methods of production and use thereof |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
WO2015100432A2 (en) | 2013-12-24 | 2015-07-02 | Symbiota, Inc. | Method for propagating microorganisms within plant bioreactors and stably storing microorganisms within agricultural seeds |
US9364005B2 (en) | 2014-06-26 | 2016-06-14 | Ait Austrian Institute Of Technology Gmbh | Plant-endophyte combinations and uses therefor |
WO2015100431A2 (en) | 2013-12-24 | 2015-07-02 | Symbiota, Inc. | Plants containing beneficial endophytes |
WO2015103438A2 (en) | 2014-01-02 | 2015-07-09 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
WO2015123205A1 (en) * | 2014-02-11 | 2015-08-20 | Children's Research Institute, Children's National Medical Center | Compositions and methods for determining the likelihood of appendicitis |
US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
CN106795192B (en) * | 2014-05-04 | 2020-06-16 | 萨利克斯药品公司 | IBS microbiota and uses thereof |
PT3145946T (en) | 2014-05-21 | 2019-11-20 | Universita¿T Basel | Bacteria-based protein delivery |
CA2952057A1 (en) | 2014-06-20 | 2015-12-23 | The Flinders University Of South Australia | Inoculants comprising actinobacterial microorganism(s) for enhancing leguminous plant growth parameter(s) |
WO2015200902A2 (en) | 2014-06-26 | 2015-12-30 | Symbiota, LLC | Endophytes, associated compositions, and methods of use thereof |
TWI689310B (en) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | Method of treating iron deficiency |
US20160016002A1 (en) * | 2014-07-17 | 2016-01-21 | John Todd Kuenstner | Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Probiotics |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
CN104546951B (en) * | 2014-09-30 | 2019-03-01 | 深圳华大基因科技有限公司 | Regular fecal bacteria is treating or preventing the application in rheumatoid arthritis or its related disease |
WO2016183531A1 (en) | 2015-05-13 | 2016-11-17 | Synlogic, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
US9688967B2 (en) | 2014-12-05 | 2017-06-27 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with hyperammonemia |
WO2016183532A1 (en) * | 2015-05-13 | 2016-11-17 | Synlogic, Inc. | Bacteria engineered to treat a disease or disorder |
KR101942955B1 (en) | 2014-12-23 | 2019-01-28 | 4디 파마 리서치 리미티드 | Immune modulation |
KR20170091157A (en) | 2014-12-23 | 2017-08-08 | 4디 파마 리서치 리미티드 | Pirin polypeptide and immune modulation |
CA2972904C (en) | 2014-12-30 | 2023-11-14 | Indigo Agriculture, Inc. | Seed endophytes across cultivars and species, associated compositions, and methods of use thereof |
RU2017141632A (en) | 2015-05-01 | 2019-06-03 | Индиго Агрикултуре, Инк. | ISOLATED COMPLEX ENDOPHITIC COMPOSITIONS AND METHODS OF IMPROVING PLANT SIGNS |
US10212944B2 (en) | 2015-05-01 | 2019-02-26 | Indigo Agriculture, Inc. | Designed complex endophyte compositions and methods for improved plant traits |
US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11883439B2 (en) | 2015-05-13 | 2024-01-30 | Synlogic Operating Company, Inc. | Bacteria engineered to treat a disease or disorder |
KR20180011262A (en) * | 2015-06-01 | 2018-01-31 | 더 유니버서티 오브 시카고 | Treatment of cancer by manipulation of symbiotic microbial guns |
WO2016196940A1 (en) * | 2015-06-05 | 2016-12-08 | Massachusetts Institute Of Technology | Compressed pathways for nonribosomal molecular biosynthesis |
CA2988764A1 (en) | 2015-06-08 | 2016-12-15 | Indigo Agriculture, Inc. | Streptomyces endophyte compositions and methods for improved agronomic traits in plants |
AU2016278067B2 (en) | 2015-06-15 | 2022-09-22 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
ES2742514T3 (en) | 2015-06-15 | 2020-02-14 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MA41010B1 (en) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MA41060B1 (en) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MX2017016529A (en) | 2015-06-15 | 2018-03-12 | 4D Pharma Res Ltd | Compositions comprising bacterial strains. |
CN108348162B (en) | 2015-08-31 | 2021-07-23 | 梅西莫股份有限公司 | Wireless patient monitoring system and method |
US11618894B2 (en) | 2015-11-16 | 2023-04-04 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
WO2017084635A1 (en) * | 2015-11-19 | 2017-05-26 | Creation Plus Biotechnology Co. Ltd. | Recombinant lactic acid bacteria and the use thereof in oral universal influenza vaccine |
IL259052B2 (en) * | 2015-11-19 | 2024-03-01 | Univ Basel | Virulence attenuated bacteria for treatment of malignant solid tumors |
WO2017085235A1 (en) | 2015-11-19 | 2017-05-26 | Universität Basel | Bacteria-based protein delivery |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
LT3209310T (en) | 2015-11-20 | 2018-04-25 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
EP3393225A4 (en) | 2015-12-21 | 2019-11-06 | Indigo AG, Inc. | Endophyte compositions and methods for improvement of plant traits in plants of agronomic importance |
CN105504030B (en) * | 2015-12-30 | 2019-09-20 | 南京林业大学 | A kind of Escherichia coli ferritin mutant removing ferroheme and the recombination system comprising it |
US11723932B2 (en) | 2016-01-11 | 2023-08-15 | Synlogic Operating Company, Inc. | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
DK3313423T3 (en) | 2016-03-04 | 2019-05-20 | 4D Pharma Plc | COMPOSITIONS INCLUDING BACTERIAL BLAUTIA STAMPS FOR TREATMENT OF VISCERAL HYPERSENSITIVITY |
JP7327773B2 (en) * | 2016-03-04 | 2023-08-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Microbial communities and their uses |
CA3019546C (en) | 2016-03-28 | 2023-05-23 | Suzhou Prajna Biotech Co., Ltd. | Anti-cancer oncolytic virus combination therapies and elite responder selection platforms |
US10617302B2 (en) | 2016-07-07 | 2020-04-14 | Masimo Corporation | Wearable pulse oximeter and respiration monitor |
TW201821093A (en) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | Compositions comprising bacterial strains |
WO2018071715A1 (en) | 2016-10-13 | 2018-04-19 | Masimo Corporation | Systems and methods for patient fall detection |
CN111164217B (en) * | 2016-11-16 | 2023-11-14 | Cj第一制糖株式会社 | Method for preparing D-psicose by using Kaistia microorganism |
WO2018102733A1 (en) | 2016-12-01 | 2018-06-07 | Indigo Ag, Inc. | Modulated nutritional quality traits in seeds |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN110325545B (en) | 2016-12-20 | 2024-02-09 | 巴塞尔大学 | Attenuated bacteria-based protein delivery |
CA3086288A1 (en) | 2016-12-23 | 2018-06-28 | The Texas A&M University System | Fungal endophytes for improved crop yields and protection from pests |
IL296740B2 (en) | 2016-12-23 | 2023-09-01 | Univ Keio | Compositions and methods for the induction of cd8+ t-cells |
CN110913875A (en) | 2017-01-06 | 2020-03-24 | 同生运营公司 | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells |
US20180236011A1 (en) * | 2017-02-22 | 2018-08-23 | Anticancer, Inc. | Methods to enhance tumor-targeting by bacteria |
EP3589128A1 (en) | 2017-03-01 | 2020-01-08 | Indigo AG, Inc. | Endophyte compositions and methods for improvement of plant traits |
EP3589116A1 (en) | 2017-03-01 | 2020-01-08 | Indigo AG, Inc. | Endophyte compositions and methods for improvement of plant traits |
US20180280542A1 (en) * | 2017-04-04 | 2018-10-04 | Ecole polytechnique fédérale de Lausanne (EPFL) | Portable bioluminescence systems and methods for in vivo monitoring of molecular and metabolic events in animals |
CA3098455A1 (en) | 2017-04-27 | 2018-11-01 | The Flinders University Of South Australia | Bacterial inoculants |
KR20200019882A (en) | 2017-05-22 | 2020-02-25 | 4디 파마 리서치 리미티드 | Compositions Containing Bacterial Strains |
MA41708A (en) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | COMPOSITIONS CONTAINING BACTERIAL STRAINS |
LT3638271T (en) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
ES2823053T3 (en) | 2017-06-14 | 2021-05-07 | 4D Pharma Res Ltd | Compositions comprising a bacterial strain of the genus Megasphaera and uses thereof |
AU2018290278B2 (en) | 2017-06-21 | 2022-12-15 | Synlogic Operating Company, Inc. | Bacteria for the treatment of disorders |
US11263707B2 (en) | 2017-08-08 | 2022-03-01 | Indigo Ag, Inc. | Machine learning in agricultural planting, growing, and harvesting contexts |
AU2018318132A1 (en) | 2017-08-14 | 2020-02-27 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
UA126082C2 (en) | 2017-09-22 | 2022-08-10 | Техніше Універзітет Ґрац | Polymeric particles containing microorganisms |
US11850270B2 (en) | 2017-12-04 | 2023-12-26 | The BioCollective, LLC | Probiotics and methods of use |
WO2019136484A1 (en) * | 2018-01-08 | 2019-07-11 | Prevail Therapeutics, Inc. | Pet imaging ligands for in vivo detection of gba1 |
AU2019217041B2 (en) | 2018-02-09 | 2022-09-15 | Keio University | Compositions and methods for the induction of CD8+ T-cells |
EP3773645A4 (en) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | Microbial consortia |
WO2019204368A1 (en) | 2018-04-19 | 2019-10-24 | Masimo Corporation | Mobile patient alarm display |
CN109234188B (en) * | 2018-08-15 | 2021-09-28 | 李晓明 | Heterotrophic nitrification aerobic denitrifying bacterium L2 and application thereof |
CN109022602B (en) * | 2018-08-27 | 2021-10-26 | 海南大学 | Primer pair, kit and detection method for detecting coral albino pathogenic vibrio alginolyticus XSBZ03 and XSBZ14 |
US20220160906A1 (en) * | 2019-03-05 | 2022-05-26 | Washington University | Compositions of and methods of making ferritin-based imaging agents |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
CN114555103A (en) * | 2019-06-03 | 2022-05-27 | 伊美诺路克斯国际公司 | Smallpox vaccines and stem cells for the treatment of disease |
US20220328193A1 (en) * | 2019-08-13 | 2022-10-13 | Tata Consultancy Services Limited | System and method for assessing the risk of prediabetes |
CN110591944A (en) * | 2019-09-06 | 2019-12-20 | 吉林大学 | Excellent clostridium butyricum for preventing ulcerative colitis |
CN114786690A (en) | 2019-10-07 | 2022-07-22 | 谢尔塔治疗公司 | Therapeutic pharmaceutical composition |
AU2021224730A1 (en) * | 2020-02-20 | 2022-09-22 | Musc Foundation For Research Development | Recombinant myxoma viruses and uses thereof |
JP2023518184A (en) | 2020-03-20 | 2023-04-28 | シンロジック オペレーティング カンパニー インコーポレイテッド | Microorganisms genetically modified to reduce hyperphenylalaninemia |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
EP3915787A1 (en) * | 2020-05-26 | 2021-12-01 | General Electric Company | Fluorescent binders for use in monitoring additive manufacturing processes |
CN111850003A (en) * | 2020-07-09 | 2020-10-30 | 华中农业大学 | Recombinant expression pasteurella multocida thiamine periplasm binding protein and application thereof |
USD974193S1 (en) | 2020-07-27 | 2023-01-03 | Masimo Corporation | Wearable temperature measurement device |
USD980091S1 (en) | 2020-07-27 | 2023-03-07 | Masimo Corporation | Wearable temperature measurement device |
CN112342164B (en) * | 2020-11-17 | 2023-08-11 | 新疆晋芳农业科技有限公司 | Rhodoblastus sphagnicola coupled microbial fertilizer and preparation and application thereof |
CN113186145A (en) * | 2021-05-19 | 2021-07-30 | 山东大学 | Tumor-targeted bacteria with visualization function, visualization method and application thereof |
USD1000975S1 (en) | 2021-09-22 | 2023-10-10 | Masimo Corporation | Wearable temperature measurement device |
CN114410554B (en) * | 2022-03-29 | 2022-06-14 | 广东省科学院生态环境与土壤研究所 | Chitin-phagocytic bacterium with aerobic arsenic methylation and volatilization functions and application thereof |
WO2023215813A1 (en) * | 2022-05-04 | 2023-11-09 | The Trustees Of Columbia University In The City Of New York | Engineered probiotics for colorectal cancer screening, prevention, and treatment |
WO2023239814A1 (en) * | 2022-06-07 | 2023-12-14 | University Of Cincinnati | Epitope-independent pretargeted therapy of cancers using bacteria |
CN114921382B (en) * | 2022-06-13 | 2023-06-16 | 中国热带农业科学院热带生物技术研究所 | Symbiotic saliospora SH098 from coral source and application thereof |
CN116334260B (en) * | 2023-03-17 | 2023-12-22 | 黑龙江中医药大学 | Metabolic biomarker for diagnosing infertility of polycystic ovary syndrome and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10209958A1 (en) * | 2002-03-06 | 2003-09-25 | Pharma Zentrale Gmbh | Escherichia coli DSM 6601 as antiphlogistic agent, useful for treating inflammatory skin diseases and rheumatic disease |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4442203A (en) | 1981-06-30 | 1984-04-10 | Massachusetts Institute Of Technology | Gene amplification assay for detecting tumor promoters |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US5833975A (en) | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US4778759A (en) | 1982-07-09 | 1988-10-18 | Boyce, Thompson Institute For Plant Research, Inc. | Genetic engineering in cyanobacteria |
US7045313B1 (en) | 1982-11-30 | 2006-05-16 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA |
JPS6327484A (en) | 1986-07-22 | 1988-02-05 | Microbial Chem Res Found | Bisucaberin and production thereof |
US5221623A (en) | 1986-07-22 | 1993-06-22 | Boyce Thompson Institute For Plant Research, Inc. | Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms |
CA1308516C (en) | 1987-07-06 | 1992-10-06 | J. William Lown | Oligopeptide anticancer and antiviral agents |
US5650148A (en) | 1988-12-15 | 1997-07-22 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
US5863542A (en) | 1991-03-07 | 1999-01-26 | Virogenetics Corporation | Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
US5212082A (en) | 1991-03-13 | 1993-05-18 | New York University | Genetically modified tyrosine hydroxylase and uses thereof |
DK0585368T3 (en) | 1991-04-25 | 1998-03-16 | Univ Brown Res Found | Implantable biocompatible immuno-insulating vehicle for delivery of selected therapeutic products |
US5554507A (en) | 1992-07-30 | 1996-09-10 | American Cyanamid Company | Bacillus subtilis siderophore genes |
EP1179350A3 (en) | 1993-08-12 | 2003-01-02 | Cytotherapeutics, Inc. | Encapsulated cell system for implantation into the human CNS |
US6491905B1 (en) | 1993-09-14 | 2002-12-10 | The Uab Research Foundation | Recombinant bacterial cells for delivery of PNP to tumor cells |
US6416754B1 (en) | 1994-03-03 | 2002-07-09 | The Board Of Trustees Of The Leland Stanford Junior University | Anaerobe targeted enzyme-mediated prodrug therapy |
US5550050A (en) | 1994-04-15 | 1996-08-27 | Cytotherapeutics, Inc. | Method for implanting encapsulated cells in a host |
US6093700A (en) | 1995-05-11 | 2000-07-25 | Thomas Jefferson University | Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF |
US6649143B1 (en) | 1994-07-01 | 2003-11-18 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US5650135A (en) | 1994-07-01 | 1997-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
AU688606B2 (en) | 1994-10-03 | 1998-03-12 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
US6045802A (en) | 1994-10-03 | 2000-04-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule |
US5693533A (en) | 1994-12-07 | 1997-12-02 | The Goodwin Institue For Cancer Research | Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing |
US6503703B1 (en) | 1995-05-19 | 2003-01-07 | Mount Sinai School Of Medicine Of New York University | Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication |
US5704910A (en) | 1995-06-05 | 1998-01-06 | Nephros Therapeutics, Inc. | Implantable device and use therefor |
US6190657B1 (en) | 1995-06-07 | 2001-02-20 | Yale University | Vectors for the diagnosis and treatment of solid tumors including melanoma |
US5646298A (en) | 1995-06-07 | 1997-07-08 | Procoron, Inc. | Cyclopropylindole prodrugs |
US5763415A (en) | 1995-08-03 | 1998-06-09 | John Hopkins University School Of Medicine | Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
US20030033617A1 (en) | 1996-04-10 | 2003-02-13 | Gyula Hadlaczky | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US20020160970A1 (en) | 1996-04-10 | 2002-10-31 | Gyula Hadlaczky | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6025155A (en) | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US6077697A (en) | 1996-04-10 | 2000-06-20 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
US5710137A (en) | 1996-08-16 | 1998-01-20 | The Trustees Of Columbia University In The City Of New York | Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype |
US5976796A (en) | 1996-10-04 | 1999-11-02 | Loma Linda University | Construction and expression of renilla luciferase and green fluorescent protein fusion genes |
US6251384B1 (en) | 1997-04-28 | 2001-06-26 | Anticancer, Inc. | Metastasis models using green fluorescent protein (GFP) as a marker |
US6232523B1 (en) | 1997-04-28 | 2001-05-15 | Anticancer, Inc. | Metastasis models using green fluorescent protein (GFP) as a marker |
US6235968B1 (en) | 1997-04-28 | 2001-05-22 | Anticancer, Inc. | Metastasis models using green fluorescent protein (GFP) as a marker |
US6713284B2 (en) | 1997-06-25 | 2004-03-30 | The United States Of America As Represented By The Secretary Of The Army | Bacterial superantigen vaccines |
US6080849A (en) | 1997-09-10 | 2000-06-27 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
JP2002500001A (en) | 1997-09-10 | 2002-01-08 | ヴァイオン ファーマシューティカルズ、インコーポレーテッド | Genetically modified tumor-targeting bacteria with reduced toxicity |
US20030044384A1 (en) | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
US6099848A (en) | 1997-11-18 | 2000-08-08 | The Trustees Of The University Of Pennsylvania | Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use |
US6106826A (en) | 1997-12-17 | 2000-08-22 | Wisconsin Alumni Research Foundation | Replication competent, avirulent Herpes simplex virus as a vector for neural and ocular gene therapy |
US6511967B1 (en) | 1999-04-23 | 2003-01-28 | The General Hospital Corporation | Use of an internalizing transferrin receptor to image transgene expression |
AU5446700A (en) | 1999-05-28 | 2000-12-18 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
US6962696B1 (en) | 1999-10-04 | 2005-11-08 | Vion Pharmaceuticals Inc. | Compositions and methods for tumor-targeted delivery of effector molecules |
US6939691B1 (en) | 1999-10-13 | 2005-09-06 | Board Of Trustees Of The Leland Stanford Junior University | E. coli and Streptomyces host cells that contain MatBC genes or E. coli host cells that contain pcc genes useful for enhanced polyketide production |
JP3593981B2 (en) | 2000-01-20 | 2004-11-24 | 日産自動車株式会社 | Method and apparatus for detecting movement amount between welding electrodes |
US6589531B1 (en) | 2000-01-21 | 2003-07-08 | The Regents Of The University Of California | Recombinant yellow fever virus and method of use thereof |
AU3457101A (en) | 2000-01-26 | 2001-08-07 | Univ Loma Linda | Method for the evaluation of implantable materials |
JP4318367B2 (en) | 2000-02-16 | 2009-08-19 | 株式会社日本触媒 | Method for producing acrolein and acrylic acid |
EP1294906B1 (en) | 2000-03-17 | 2009-01-21 | Anticancer, Inc. | Whole-body optical imaging of gene expression and uses thereof |
GB0007433D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Recombinant transferrin binding proteins |
AU2001272011A1 (en) | 2000-06-19 | 2002-01-02 | Regents Of The University Of Minnesota | Siderophores-producing bifidobacteria thereby and uses thereof |
US20020054865A1 (en) | 2000-09-21 | 2002-05-09 | Minoru Fujimori | Anaerobic bacterium as a drug for cancer gene therapy |
JP3642755B2 (en) | 2000-09-21 | 2005-04-27 | 純 天野 | Drugs for gene therapy using anaerobic bacteria |
WO2002031155A2 (en) | 2000-10-13 | 2002-04-18 | Ecopia Biosciences Inc. | Gene cluster for ramoplanin biosynthesis |
US6623721B2 (en) | 2000-12-18 | 2003-09-23 | Draximage, Inc. | Bifunctional chelating compounds containing hydroxamic acid residues |
US20050064447A1 (en) | 2001-04-18 | 2005-03-24 | Sheng-He Huang | Probiotic therapy of neonatal meningitis and method of using E. coli virulence determinatns |
WO2002094271A1 (en) | 2001-05-15 | 2002-11-28 | Faulk Pharmaceuticals, Inc. | Targeted delivery of bioaffecting compounds for the treatment of cancer |
JP2005520781A (en) | 2001-07-09 | 2005-07-14 | アンチキャンサー インコーポレーテッド | Imaging infection using fluorescent proteins as markers |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
EP1281772A1 (en) | 2001-07-31 | 2003-02-05 | Aladar A. Szalay | Light-emitting microorganisms and cells for tumour diagnosis/therapy |
US20030198627A1 (en) | 2001-09-01 | 2003-10-23 | Gert-Jan Arts | siRNA knockout assay method and constructs |
KR101142380B1 (en) | 2001-12-31 | 2012-05-18 | 안티캔서, 인코포레이티드 | System for monitoring bacterial tumor treatment |
DK1487499T3 (en) | 2002-03-07 | 2009-07-20 | Univ Carnegie Mellon | Contrast agents for magnetic resonance imaging and related methods |
AU2003219057A1 (en) | 2002-03-15 | 2003-09-29 | Baxter Healthcare S.A. | Recombinant drug-sensitive vaccinia virus as smallpox vaccine |
US20030228261A1 (en) | 2002-06-05 | 2003-12-11 | Aladar Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
EP1369491A1 (en) | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
WO2004078124A2 (en) | 2003-03-03 | 2004-09-16 | Board Of Regents, The University Of Texas System | Methods and compositions involving mda-7 |
US20040186087A1 (en) | 2003-03-20 | 2004-09-23 | Ceramoptec Industries, Inc. | Siderophore conjugates of photoactive dyes for photodynamic therapy |
EP1489164A1 (en) | 2003-06-18 | 2004-12-22 | Genelux GmbH | Recombinant vaccinia viruses with modified F3 genes, uses thereof |
EP1526185B1 (en) | 2003-10-22 | 2012-09-12 | Genelux Corporation | Use of a microorganism or cell to induce autoimmunization of an organism against a tumor |
AU2004289953B2 (en) | 2003-06-18 | 2008-09-25 | Genelux Corporation | Modified recombinant vaccina viruses and other microorganisms, uses thereof |
ATE445017T1 (en) | 2003-08-14 | 2009-10-15 | Genelux Corp | METHOD FOR PRODUCING A POLYPEPTIDE, RNA OR OTHER COMPOUND IN TUMOR TISSUE |
TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
EP2415783B1 (en) | 2006-10-16 | 2016-12-14 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
EP1958647A1 (en) | 2007-02-15 | 2008-08-20 | Helmholtz-Zentrum für Infektionsforschung GmbH | Pharmaceutical composition with bacteria for tumor treatment |
WO2008150496A2 (en) | 2007-05-31 | 2008-12-11 | Genelux Corporation | Assay for sensitivity to chemotherapeutic agents |
CA2690627C (en) | 2007-06-15 | 2014-12-02 | Genelux Corporation | Microorganisms for imaging and/or treatment of tumors |
US20090162288A1 (en) | 2007-07-18 | 2009-06-25 | Nanhai Chen | Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods |
US20090136917A1 (en) | 2007-10-25 | 2009-05-28 | Szalay Aladar A | Systems and methods for viral therapy |
EP2242516A1 (en) | 2008-01-11 | 2010-10-27 | Genelux Corporation | Methods and compositions for detection of bacteria and treatment of diseases and disorders |
-
2007
- 2007-07-10 TW TW096125060A patent/TW200819540A/en unknown
- 2007-07-11 WO PCT/US2007/015829 patent/WO2008073148A2/en active Search and Examination
- 2007-07-11 EP EP07870721.3A patent/EP2044436B1/en active Active
- 2007-07-11 US US11/827,518 patent/US7763420B2/en active Active
-
2008
- 2008-01-11 US US12/008,659 patent/US7820184B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10209958A1 (en) * | 2002-03-06 | 2003-09-25 | Pharma Zentrale Gmbh | Escherichia coli DSM 6601 as antiphlogistic agent, useful for treating inflammatory skin diseases and rheumatic disease |
Non-Patent Citations (8)
Title |
---|
ALTENHOEFER ARTUR ET AL: "The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 40, no. 3, 9 April 2004 (2004-04-09), pages 223 - 229, XP002492185, ISSN: 0928-8244 * |
BRADER PETER ET AL: "Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 15 APR 2008, vol. 14, no. 8, 15 April 2008 (2008-04-15), pages 2295 - 2302, XP002492189, ISSN: 1078-0432 * |
LIEBREGTS T ET AL: "Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model.", NEUROGASTROENTEROLOGY AND MOTILITY : THE OFFICIAL JOURNAL OF THE EUROPEAN GASTROINTESTINAL MOTILITY SOCIETY JUN 2005, vol. 17, no. 3, June 2005 (2005-06-01), pages 410 - 414, XP002492187, ISSN: 1350-1925 * |
PATZER S I ET AL: "The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.", MICROBIOLOGY (READING), vol. 149, no. 9, September 2003 (2003-09-01), pages 2557 - 2570, XP002492188, ISSN: 1350-0872 * |
SCHULTZ MICHAEL ET AL: "Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, vol. 11, no. 2, March 2004 (2004-03-01), pages 372 - 378, XP002492186, ISSN: 1071-412X * |
STRITZKER ET AL: "Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice", INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, URBAN UND FISCHER, DE, vol. 297, no. 3, 6 May 2007 (2007-05-06), pages 151 - 162, XP022063055, ISSN: 1438-4221 * |
WESTENDORF A M ET AL: "Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, ELSEVIER SCIENCE B.V., AMSTERDAM, NL, vol. 43, no. 3, 1 March 2005 (2005-03-01), pages 373 - 384, XP004749346, ISSN: 0928-8244 * |
YU YONG A ET AL: "Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 22, no. 3, 1 March 2004 (2004-03-01), pages 313 - 320, XP002331816, ISSN: 1087-0156 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9005602B2 (en) | 2006-10-16 | 2015-04-14 | Genelux Corporation | Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
CN102242081B (en) * | 2010-03-17 | 2013-01-02 | 中国人民解放军南京军区南京总医院 | Super paramagnetic iron oxide particle marked cell for magnetic-resonance tracing in vivo |
US8859256B2 (en) | 2011-10-05 | 2014-10-14 | Genelux Corporation | Method for detecting replication or colonization of a biological therapeutic |
Also Published As
Publication number | Publication date |
---|---|
EP2044436B1 (en) | 2014-06-04 |
EP2044436A2 (en) | 2009-04-08 |
US20090180987A1 (en) | 2009-07-16 |
US20080193373A1 (en) | 2008-08-14 |
US7820184B2 (en) | 2010-10-26 |
TW200819540A (en) | 2008-05-01 |
WO2008073148A2 (en) | 2008-06-19 |
US7763420B2 (en) | 2010-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008073148A3 (en) | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders | |
EP3552607A3 (en) | Imidazopyrazine syk inhibitors | |
Piha-Paul et al. | Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours | |
EP2926827A3 (en) | Therapeutic Peptidomimetic Macrocycles | |
WO2010063011A3 (en) | Methods for the treatment of infections and tumors | |
WO2010042815A3 (en) | Vhh antibody fragments for use in the detection and treatment of cancer | |
WO2009067397A3 (en) | Treatment for solid tumors | |
WO2007109571A3 (en) | Methods of predicting and monitoring tyrosine kinase inhibitor therapy | |
WO2009139921A3 (en) | Microorganisms for preventing and treating neoplasms accompanying cellular therapy | |
WO2008027837A3 (en) | Small molecule potentiator of hormonal therapy for breast cancer | |
MX2007009649A (en) | Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer. | |
EP2527466A3 (en) | Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
WO2004096224A3 (en) | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis | |
WO2008103645A3 (en) | Prostate cancer and melanoma antigens | |
WO2007146229A3 (en) | Markers associated with arteriovascular events and methods of use thereof | |
EP2985281A3 (en) | Isoindoline compounds for use in the treatment of cancer | |
WO2009008992A3 (en) | Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mt0rc2 | |
WO2010093789A3 (en) | A composition comprising (-) -trans-3- (5, 6-dihydro-4h-pyrrolo [3,2,1-ij] quinolin-l-yl)-4-(lh-indol-3-yl) pyrrolidine- 2, 5-dione in combination with a second anti-proliferative agent | |
WO2007149456A3 (en) | Methods and compositions for diagnostic and therapeutic targeting of cox-2 | |
WO2010004590A3 (en) | Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment | |
WO2010051320A3 (en) | Methods for assembling panels of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositions | |
WO2009073575A3 (en) | Methods for treating induced cellular proliferative disorders | |
MX369028B (en) | Methods and systems for identifying and treating anti-progestin sensitive tumors. | |
EP1744162A4 (en) | Cancer diagnosis and treatment using anti-robo1 antibody | |
Horisberger et al. | Impaired continence function five years after intensified chemoradiation in patients with locally advanced rectal cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07870721 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007870721 Country of ref document: EP |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) |